banner
uchicagocancer.bsky.social
UChicago Cancer
@uchicagocancer.bsky.social
240 followers 98 following 170 posts
Joint account for the NCI-designated UChicago Medicine Comprehensive Cancer Center and the University of Chicago's Section of Hematology/Oncology. At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
www.uchicagomedicine.org
Posts Media Videos Starter Packs
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 15h
Our faculty in the media!! 👩‍⚕️👨‍⚕️

Dr. Chen is on @abc7chicago.bsky.social talking about #BreastCancerAwarenessMonth (abc7chicago.com/post/chicago...)
and
Dr. Sweis on @onclive.bsky.social sharing about a novel treatment approach to renal cell carcinoma (www.onclive.com/view/dual-bi...)

#AtTheForefront
Our Chicago: Breast Cancer Awareness Month
Breast cancer is the most common cancer in women here in the U.S., second only to skin cancers. For 2025, the American Cancer Society estimates that nearly 317 thousand new cases of invasive breast ca...
abc7chicago.com
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 1d
Yu-Ying He, PhD, and team published a new study in Cell Reports demonstrating that arsenic exposure promotes skin tumorigenesis through upregulation of ALKBH1, identifying ALKBH1 as a potential druggable target and biomarker for arsenic tumorigenicity.
ow.ly/8as150X7pSW
Arsenic regulates ALKBH1 abundance and substrate specificity to promote translation and tumorigenicity
Wilkinson and Cui et al. show that the protein ALKBH1 binds to arsenic and is up-regulated by arsenic, leading to increased m6A RNA demethylase activity of ALKBH1, and thus acts as a critical factor i...
ow.ly
1
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 5d
Lisa Howard, a multiple myeloma survivor, credits clinical trials for helping her achieve remission. Now she is a patient advocate, guiding newly diagnosed cancer patients, particularly the black patients to explore clinical trial options.
Read her story here: ow.ly/1yuP50X5Ufw
Cancer survivor encourages Black patients to enroll in clinical trials - UChicago Medicine
Participating in a clinical trial inspired cancer survivor Lisa Howard to help others by becoming a patient advocate.
ow.ly
Reposted by UChicago Cancer
ash.hematology.org
American Society of Hematology @ash.hematology.org · 5d
Rohan, who has acute myeloid leukemia, says he’s alive today because of federally funded research. His story is a powerful reminder: Research saves lives. Learn more: https://ow.ly/xH3q50X4EOI

#Fight4Hematology #ResearchSavesLives #Leusm #HemeOnc
3 7
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 6d
October marks #BreastCancerAwarenessMonth.
Did you know #mammogram can detect #breastcancer in its early and most treatable stages?
Sarah Shubeck, MD, MS, breast surgical oncologist at UChicago Medicine, explains both the benefits and anxieties around mammograms.
Read here: ow.ly/8afs50X5Euo
Overcoming mammogram anxiety: What a breast cancer expert wants you to know - UChicago Medicine
A UChicago Medicine breast surgical oncologist explains the benefits of breast cancer screenings and offers tips on how to navigate stressors that may arise before, during and after a mammogram.
ow.ly
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 7d
For #BreastCancerAwarenessMonth, watch this video about what to expect when going for a routine mammogram. #BCAM #cancerscreening www.youtube.com/shorts/0DV8A...
Mammograms at UChicago Medicine
YouTube video by UChicago Medicine
www.youtube.com
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 12d
Construction on our new Cancer Pavilion is progressing quickly and we're especially glad that it's being built with extra attention to the chemicals and materials being used. Learn more about these efforts & why they matter: essentialhospitals.org/uchicago-aim...
UChicago Aims to Avoid Chemicals of Concern in New Cancer Center
Association corporate affiliate member CannonDesign is helping UChicago create healthier buildings and boost health outcomes for patients and staff through sustainable and nontoxic material choices.
essentialhospitals.org
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 13d
In a recent OncLive podcast, Rita Nanda, MD joins Filipa Lynce, MD to discuss the latest clinical trial and real-world data on antibody drug conjugates used in the treatment of triple negative breast cancer. @danafarber.bsky.social @onclive.bsky.social
ow.ly/hAwn50X2t3h
Dissecting Clinical Trial and Real-World Data for ADCs in TNBC | OncLive
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
ow.ly
1 2
Reposted by UChicago Cancer
ktsanov.bsky.social
Kal Tsanov @ktsanov.bsky.social · 13d
Our growing team at @uchicagocancer.bsky.social is building on these concepts, with the goal of translating this knowledge to improved therapies for metastatic cancers. More to come! (4/4)
2 2
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 20d
Team Thoracic Park is back!
It’s time again for UChicago Medicine to participate in
@lcrf.org annual "Free to Breathe" Chicago Walk on 10/5. To register and/or donate: visit lcrf.org/UChicago
2025 Free to Breathe Chicago Walk
{{MetaTags.description}}
LCRF.org
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 20d
🚨 New article alert!! 🚨

A great new piece in Annals of Oncology about the benefits of anthracyclines in certain types of #BreastCancer: www.annalsofoncology.org/article/S092...

from Drs. @fredhow.bsky.social, Chen, & others!
Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer
The benefit of anthracyclines for patients with high 21-gene recurrence score (RS) is unclear, despite the widespread use of RS to guide adjuvant chemotherapy treatment for hormone receptor-positive (...
www.annalsofoncology.org
3
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 20d
A beautiful tribute to a giant in our field and institution, Dr. Golomb
cancerletter.com
The Cancer Letter @cancerletter.com · 25d
Harvey Golomb, past chair of UChicago’s Department of Medicine (@uchicagocancer.bsky.social), dies at 82. Obituary by Everett E. Vokes
https://cancerletter.com/obituary/20250912_5/
Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82 Golomb was a translational scientist (before that term was in vogue) - The Cancer Letter
It is with profound sadness that I announce the passing of our esteemed colleague and friend, Dr. Harvey Golomb. He died on Aug. 20. Dr. Golomb had a highly successful career as a translational scientist before that word was in vogue, later as a leader of ASCO, and institutionally as section chief from 1981 to […]
cancerletter.com
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 21d
Susan Cohn, MD, and her team are advancing neuroblastoma research through decades of work building a global, open-access data commons, enabling researchers and clinicians worldwide to share and access critical data.
ow.ly/LXcO50WY9a8
Data-sharing efforts create breakthroughs in pediatric cancer research
UChicago researchers reflect on 20 years of work building an ecosystem for sharing pediatric cancer data.
ow.ly
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 22d
Susan Cohn, MD, and her team are advancing neuroblastoma research through decades of work building a global, open-access data commons, enabling researchers and clinicians worldwide to share and access critical data.
ow.ly/1h5h50WXJAG
Data-sharing efforts create breakthroughs in pediatric cancer research
UChicago researchers reflect on 20 years of work building an ecosystem for sharing pediatric cancer data.
ow.ly
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 26d
Thanks to Dr. Polite for not only sharing the importance of #colonoscopy screening but showing us all what the process is like from start to finish! Join Dr. Polite & talk with your care team about your own screenings!
www.uchicagomedicine.org/forefront/pr...
Colonoscopy made simple: Physician highlights important, easy-to-schedule screenings at UChicago Medicine Crown Point - UChicago Medicine
Dr. Blase Polite, physician-in-chief at UChicago Medicine Crown Point, shares his own colonoscopy experience at the Crown Point multispecialty facility.
www.uchicagomedicine.org
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 27d
Check out the latest updates from the NCCN on NSCLC treatment guidelines, emphasizing the incorporation of immune checkpoint inhibitors and targeted therapies in the management of resectable NSCLC.
ow.ly/Bfz450WVq2n
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 27d
Congratulations to the UChicago/Infleqtion team who were recently announced as a Phase 1 winner for the NIH Quantum Sensing Technology Challenge!! Learn more about their project at www.challenge.gov?challenge=ni...

@uchicagomedicine.bsky.social

#AtTheForefront
Challenge.gov
Challenge.gov is the official government website supporting prize challenges and prize competitions that are sponsored by the US federal government. Here federal agencies provide prize awards to publi...
www.challenge.gov
2
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 28d
Come join our team!!🤝

The Patnaik Lab is hiring Research Assistant Professors in developmental therapeutics & immuno-oncology to focus on therapeutics for immune-refractory cancers. Learn more/apply at apply.interfolio.com/168470
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio
apply.interfolio.com
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 29d
A new study published in @gynoncjnls shows that delivering care at high-resource tertiary centers may eliminate racial and socioeconomic disparities in women with treatable stage I-III endometrioid endometrial cancer. @uchicagoobgyn.bsky.social
ow.ly/hWtP50WUb7F
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center - PubMed
In women with Stage I-III EEC treated at a single tertiary referral center, we did not find differences in outcomes when analyzed by ADI or race. Given previously reported racial disparities in outcom...
ow.ly
1 1
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · 29d
Looking forward to the upcoming Jonas Center Cellular Therapy Symposium? Don't forget about the satellite symposium the day before, perfect for trainees and emerging scientists on your team! Registration (free of charge!) can be found at www.jonascentersymposium.com/satellite-sy...
Reposted by UChicago Cancer
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · Aug 29
In a new commentary Freeman et al. points out that patients with ER-low tumors may not benefit from estrogen therapy in adjuvant setting, suggesting re-evaluation of systemic treatment strategies. #ERLowBreastCancer #PrecisionMedicine
@uchicagoobgyn.bsky.social
ow.ly/Leto50WObj7
1 4
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · Sep 8
A new study from the University of Chicago links higher financial toxicity (FT) with lower quality of life and increased psychological distress in cancer patients, suggesting that screening for FT could improve emotional and physical well-being. @uchicagomedicine.bsky.social
ow.ly/ffTK50WTmcp
Research exposes far-reaching toll of financial hardship on cancer patients - UChicago Medicine
A new study from UChicago Medicine confirmed that cancer patients experiencing greater financial toxicity reported more psychological distress and worse health-related quality of life.
ow.ly
1
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · Sep 3
In the latest #TheImmunoVerse episode, @PatrickHwuMD sits with Thomas Gajewski, MD, PhD to discuss on how the tumor microenvironment, genetics & gut microbiome shape immune responses — and the future of #immunotherapy. @moffittnews.bsky.social
Listen here: ow.ly/ta0F50WQLv8
Hot vs. Cold Tumors: Decoding the Tumor Microenvironment
Dr. Gajewski discusses his pioneering work defining “hot” versus “cold” tumors — an insight that transformed how immunotherapists understand tumor response.
ow.ly
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · Sep 3
We're less than a month out from the #JonasCenterSymposium on cellular therapy! Held on campus & led by our experts, it promises to be a day of learning & community building! Co-hosted with @medicalcollegeofwi.bsky.social and @washumedicine.bsky.social!!
More at www.jonascentersymposium.com
Jonas Center Cellular Therapy Symposium
www.jonascentersymposium.com
1
uchicagocancer.bsky.social
UChicago Cancer @uchicagocancer.bsky.social · Sep 2
In a new study, Jing Chen, PhD, and team demonstrates that zeaxanthin, a plant-based nutrient, acts as an immunomodulator—boosting CD8+ T cell function and enhancing the effects of immunotherapy. @cellpress.bsky.social @uchicagobsd.bsky.social ow.ly/jFGo50WPJBG
Plant-based nutrient improves immune cells’ ability to fight cancer
Researchers find that zeaxanthin, best known for protecting vision, can also strengthen the cancer-fighting activity of immune cells.
ow.ly
1 2